Collaboration opportunities

Slide view

List view

Ends: 75d 1h 42min

Maximising the value of your assets for patients suffering from a dermatological condition

For scientists at biotechs, start-ups, pharmaceutical companies, Universities, and research institutions.

Open from 20/07/22 to 31/10/22

Pharmacological profile of your asset & partnership opportunity

Submit your proposal at any time

If your idea does not fit with our current initiatives, share it with us here.

For scientists at Universities, Research institutions, biotechs, start-ups and pharmaceutical companies

Submit your proposal at any time

We make your project happen

Why partner with us


AlmirallShare offers an opportunity for learning from each other, sharing knowledge and efforts

Closeness

Help on project implementation

Collaboration

Fair partnership and open communication

Support

We make your project happen

Trust

Your idea is safely managed

What we have achieved

Subscribe to our latest news

AlmirallShare News

AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases

Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo

Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa